At a Glance
- Tasks: Lead bioanalytical strategies and bridge AI design with preclinical execution.
- Company: Isomorphic Labs, pioneering AI for groundbreaking drug discovery.
- Benefits: Innovative work culture, competitive salary, and opportunities for professional growth.
- Other info: Fast-paced environment with a focus on collaboration and innovation.
- Why this job: Join a mission to revolutionise medicine and tackle global health challenges.
- Qualifications: 8+ years in bioanalytical strategy with expertise in small molecules and biologics.
The predicted salary is between 70000 - 90000 £ per year.
Isomorphic Labs is applying frontier AI to help unlock deeper scientific insights, faster breakthroughs, and life-changing medicines with an ambition to solve all disease.
The future is coming.
A future enabled and enriched by the incredible power of machine learning.
A future in which diseases are curtailed or cured starting with better and faster drug discovery.
Come and be part of an interdisciplinary team driving groundbreaking innovation and play a meaningful role in contributing towards us achieving our ambitious goals, while being a part of an inspiring and collaborative culture.
The world we want tomorrow is the one we’re building today.
It starts with the culture at this company.
It starts with you.
About Iso Isomorphic Labs (Iso Labs) was launched in 2021 to advance human health by building on and beyond the Nobel-winning Alpha Fold system.
Since then, our interdisciplinary team of drug discovery experts and machine learning specialists has built powerful new predictive and generative AI models that accelerate scientific discovery at digital speed.
Our name comes from the belief that there is an underlying symmetry between biology and information science.
By harnessing AI’s powerful capabilities, we can use it to model complex biological phenomena to help design novel molecules, anticipate how drugs will perform and develop innovative medicines to treat and cure some of the world’s most devastating diseases.
We have built a world-leading drug design engine comprising AI models that are capable of working across multiple therapeutic areas and drug modalities.
We are continually innovating on model architecture and developing cutting‑edge capabilities to advance rational drug design.
Every day, and with each new breakthrough, we’re getting closer to the promise of digital biology, and achieving our ambitious mission to one day solve all disease with the help of AI.
Your mission We are seeking a highly innovative and experienced Bioanalytical Lead to bridge the gap between our predictive AI design platform and wet‑lab preclinical execution.
In this role, you will define the overarching bioanalytical strategy across our expanding portfolio, covering small molecules, advanced biologic formats, and Antibody‑Drug Conjugates (ADCs) in both non‑GLP and GLP environments.
You will collaborate closely with the drug design teams, design robust bioanalytical assays, manage global Contract Research Organizations (CROs), and lead the logistical execution required to rapidly advance our candidates toward IND submission.
As the Bioanalytical Lead, you will serve as the technical expert for our diverse portfolio of computationally designed therapeutic candidates.
As part of the preclinical development function, this is a high‑impact leadership role responsible for building the bridge between Isomorphic’s AI‑driven discovery engine and the effective execution of our robust preclinical strategies, alongside safety and DMPK.
The successful candidate will be forward thinking, thrive in fast‑paced, agile environment and ready to embrace Iso’s AI‑first mindset and challenge the status quo.
With a broad range of internal and external stakeholders, candidates will be expected to have exceptional communication and influencing skills.
Bioanalytical Strategy OR a B.
S./M.
S. with 8+ years of equivalent experience.
Proven track record of leading bioanalytical strategies across multiple modalities (must include small molecules, biologics, and ADCs).
Deep understanding of GLP and non‑GLP preclinical study regulations, FDA/EMA bioanalytical method validation guidelines, and ICH guidelines.
Technical